• Dr Bhuvaneshwari
• Dr Akash B
• Dr Prof Shripathi Acharya

In the practice of medicine, herbs are used as therapeutic agent since long time. In Ayurveda medicine, drugs are prepared from herbal, mineral and animal products. Prevention of disease and management of diseases are the main objective of Ayurveda medicine. Dinacharya ( daily regimen ) , Rutucharya ( Seasanal regimen ), and Sadvritta ( following Codes of good conduct ) are advised for the prevention of diseases. Ashwagandha ( Withania somnifera) ais a drug which is commonly used in the management of neurological disorders and psychiatry. Since it is a Jivaniya, Ojaskara and Rasayana drug, it is commonly used in chronic and debilitating diseases. Especially in the management of various non communicable diseases, Ashwagandha is utilized in the treatment. Ashwagandha is having the actions like Rasayana, Jivaniya, Vayasthapana, Balya, Brimhana, Nidrakara, Poshaka, Vedanasthapana, Nadibalya, immunomodulator, immunity booster, antistress, adaptogenic, antioxidant, anticancer, antiaging and sedative actions. It is usually effective in diseases like insomnia, systemic hypertention, Polyneuritis Sciatica syndrome, Diabetic neuropathy, Cervical spondylosis, Lumbar Spondylosis, Osteoarthritis of the Knee joint Mania, Maniac depressive psychosis, epilepsy and brachial neuralgia. The present paper highlights about the clinical indications of Ashwagandha ( Withania somnifera ) in a scientific and experiential view.

Ashwagandha, Rasayana, immunomodulator, antioxidant.

"Clinical indications of Ashwagandha ( Withania somnifera ) an experiential and scientific view", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.13, Issue 1, page no.c372-c375, January-2026, Available :http://www.jetir.org/papers/JETIR2601243.pdf

"Clinical indications of Ashwagandha ( Withania somnifera ) an experiential and scientific view", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.13, Issue 1, page no. ppc372-c375, January-2026, Available at : http://www.jetir.org/papers/JETIR2601243.pdf